TR200103221T2 - Heterosiklik olarak ikame edilmiş benzimidazoller, bunların üretimi ve uygulanması - Google Patents
Heterosiklik olarak ikame edilmiş benzimidazoller, bunların üretimi ve uygulanmasıInfo
- Publication number
- TR200103221T2 TR200103221T2 TR2001/03221T TR200103221T TR200103221T2 TR 200103221 T2 TR200103221 T2 TR 200103221T2 TR 2001/03221 T TR2001/03221 T TR 2001/03221T TR 200103221 T TR200103221 T TR 200103221T TR 200103221 T2 TR200103221 T2 TR 200103221T2
- Authority
- TR
- Turkey
- Prior art keywords
- production
- application
- heterocyclic substituted
- substituted benzimidazoles
- benzimidazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Abstract
Bu bulus yeni benzimidazoller, bunlarin üretimi ve enzimi poli(ADP-riboz) polimeraz ya da PARP (EC 2.4.2.30) önleyiciler olarak ilaç üretiminde kullanilmasiyla ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19920936A DE19920936A1 (de) | 1999-05-07 | 1999-05-07 | Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200103221T2 true TR200103221T2 (tr) | 2002-04-22 |
Family
ID=7907219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/03221T TR200103221T2 (tr) | 1999-05-07 | 2000-04-27 | Heterosiklik olarak ikame edilmiş benzimidazoller, bunların üretimi ve uygulanması |
Country Status (27)
Country | Link |
---|---|
US (1) | US6696437B1 (tr) |
EP (1) | EP1177178B1 (tr) |
JP (1) | JP4004737B2 (tr) |
KR (1) | KR20010112477A (tr) |
CN (1) | CN1353695A (tr) |
AR (1) | AR029161A1 (tr) |
AT (1) | ATE286029T1 (tr) |
AU (1) | AU4558400A (tr) |
BG (1) | BG106035A (tr) |
BR (1) | BR0010342A (tr) |
CA (1) | CA2371645C (tr) |
CO (1) | CO5170517A1 (tr) |
DE (2) | DE19920936A1 (tr) |
DK (1) | DK1177178T3 (tr) |
ES (1) | ES2235869T3 (tr) |
HK (1) | HK1046281A1 (tr) |
HU (1) | HUP0202970A2 (tr) |
IL (1) | IL146147A0 (tr) |
MY (1) | MY122771A (tr) |
NO (1) | NO20015362L (tr) |
PL (1) | PL351558A1 (tr) |
PT (1) | PT1177178E (tr) |
SK (1) | SK15962001A3 (tr) |
TR (1) | TR200103221T2 (tr) |
UA (1) | UA68436C2 (tr) |
WO (1) | WO2000068206A1 (tr) |
ZA (1) | ZA200108609B (tr) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200101239T2 (tr) | 1998-11-03 | 2001-11-21 | Basf Aktiengesellschaft | İkameli-2-fenilbenzimidazoller, üretimleri ve kullanımları |
ES2220753T3 (es) * | 2000-03-20 | 2004-12-16 | N-Gene Research Laboratories Inc. | Derivados de amidoxina del acido propencarboxilico, procedimiento para su preparacion, y composiciones farmaceuticas que los contienen. |
MXJL03000027A (es) | 2001-03-12 | 2004-04-30 | Avanir Pharmaceuticals | Compuestos de benzimidazol para modular la ige e inhibir la proliferacion celular. |
WO2002101073A2 (en) * | 2001-06-13 | 2002-12-19 | Genesoft Pharmaceuticals, Inc. | Aryl-benzimidazole compounds having antiinfective activity |
WO2003004488A1 (en) | 2001-07-03 | 2003-01-16 | Chiron Corporation | Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
US7642278B2 (en) | 2001-07-03 | 2010-01-05 | Novartis Vaccines And Diagnostics, Inc. | Indazole benzimidazole compounds |
KR20040084896A (ko) * | 2002-02-06 | 2004-10-06 | 버텍스 파마슈티칼스 인코포레이티드 | Gsk-3의 억제제로서 유용한 헤테로아릴 화합물 |
DE10227668A1 (de) * | 2002-06-20 | 2004-01-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arzneimittel zur Behandlung des systemic inflammatory response syndrome |
CA2493364A1 (en) | 2002-07-26 | 2004-02-12 | Basf Plant Science Gmbh | Inversion of the negative-selective effect of negative marker proteins using selection methods |
AU2003258022A1 (en) | 2002-08-02 | 2004-02-23 | Genesoft Pharmaceuticals, Inc. | Biaryl compounds having anti-infective activity |
AU2003257329C1 (en) | 2002-08-19 | 2010-07-22 | Lorus Therapeutics Inc. | 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
TWI276631B (en) | 2002-09-12 | 2007-03-21 | Avanir Pharmaceuticals | Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
AU2003270426A1 (en) | 2002-09-12 | 2004-04-30 | Avanir Pharmaceuticals | PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
JP4520406B2 (ja) | 2002-10-01 | 2010-08-04 | 田辺三菱製薬株式会社 | イソキノリン化合物及びその医薬用途 |
AU2003285958A1 (en) | 2002-10-25 | 2004-05-25 | Genesoft Pharmaceuticals, Inc. | Anti-infective biaryl compounds |
JP4567460B2 (ja) | 2002-11-22 | 2010-10-20 | 田辺三菱製薬株式会社 | イソキノリン化合物及びその医薬用途 |
EP1587529A4 (en) | 2002-12-10 | 2009-08-12 | Oscient Pharmaceuticals Corp | ANTIBACTERIAL COMPOUNDS HAVING A PATTERN (CARBOXAMIDE PYRROLE) - (BENZAMIDE) - (IMIDAZOLE CARBOXAMIDE) |
SE0301371D0 (sv) * | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | New Compounds |
TWI372050B (en) * | 2003-07-03 | 2012-09-11 | Astex Therapeutics Ltd | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles |
WO2005081687A2 (en) * | 2003-09-30 | 2005-09-09 | Centocor, Inc. | Human hinge core mimetibodies, compositions, methods and uses |
NZ546259A (en) * | 2003-09-30 | 2009-05-31 | Janssen Pharmaceutica Nv | Benzoimidazole compounds |
DK1692113T3 (en) | 2003-11-14 | 2018-01-08 | Lorus Therapeutics Inc | ARYLIMIDAZOLES AND USE THEREOF AS ANTICANCES |
FR2862971B1 (fr) * | 2003-11-28 | 2006-03-24 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament |
GB0400781D0 (en) * | 2004-01-14 | 2004-02-18 | Novartis Ag | Organic compounds |
US8110573B2 (en) * | 2004-12-30 | 2012-02-07 | Astex Therapeutics Limited | Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases |
WO2006070192A1 (en) * | 2004-12-30 | 2006-07-06 | Astex Therapeutics Limited | Thiazole and isothiazole derivatives that modulate the acivity of cdk, gsk and aurora kynases |
KR20060087386A (ko) * | 2005-01-28 | 2006-08-02 | 주식회사 대웅제약 | 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물 |
EP1861387B1 (en) * | 2005-01-28 | 2014-04-16 | Daewoong Pharmaceutical Co., Ltd. | Benzimidazole derivatives and pharmaceutical compositions thereof |
CN101137752B (zh) | 2005-03-08 | 2013-04-03 | 巴斯福植物科学有限公司 | 增强表达的内含子序列 |
WO2006099379A2 (en) * | 2005-03-14 | 2006-09-21 | Transtech Pharma, Inc. | Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
US7728026B2 (en) | 2005-04-11 | 2010-06-01 | Abbott Laboratories, Inc. | 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors |
TWI375673B (en) * | 2005-04-11 | 2012-11-01 | Abbott Lab | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
ES2473597T3 (es) | 2005-05-25 | 2014-07-07 | Lorus Therapeutics Inc. | Derivados de 2-indolil imidazo[4,5-d]fenantrolina y su uso en el tratamiento del cáncer |
WO2007041357A1 (en) * | 2005-09-29 | 2007-04-12 | Abbott Laboratories | 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
EP1960382A1 (en) * | 2005-11-03 | 2008-08-27 | ChemBridge Research Laboratories, Inc. | Heterocyclic compounds as tyrosine kinase modulators |
CA2628461C (en) | 2005-11-15 | 2013-09-24 | Abbott Laboratories | Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
EP1968579A1 (en) * | 2005-12-30 | 2008-09-17 | Astex Therapeutics Limited | Pharmaceutical compounds |
EP2338487B1 (en) * | 2006-01-17 | 2013-09-11 | Abbott Laboratories | Combination therapy with PARP inhibitors |
CA2647545C (en) * | 2006-04-03 | 2016-02-23 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors |
CA2647373C (en) * | 2006-05-02 | 2014-03-18 | Abbott Laboratories | Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
US8435970B2 (en) * | 2006-06-29 | 2013-05-07 | Astex Therapeutics Limited | Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea |
EP2043635A2 (en) * | 2006-06-29 | 2009-04-08 | Astex Therapeutics Limited | Pharmaceutical combinations |
RS51780B (en) | 2007-01-10 | 2011-12-31 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. | INDASOLS SUBSTITUTED BY AMIDE AS INHIBITORS OF POLY (ADP-Ribose) POLYMERASES (PARP) |
US8067613B2 (en) * | 2007-07-16 | 2011-11-29 | Abbott Laboratories | Benzimidazole poly(ADP ribose)polymerase inhibitors |
US20090062268A1 (en) * | 2007-08-27 | 2009-03-05 | Lead Therapeutics, Inc. | Novel inhibitors of poly(adp-ribose)polymerase (parp) |
NZ585999A (en) * | 2007-12-07 | 2011-05-27 | Prana Biotechnology Ltd | Transition metal complexes for therapy and diagnosis |
US8436185B2 (en) | 2008-01-08 | 2013-05-07 | Merck Sharp & Dohme Corp. | Pharmaceutically acceptable salts of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide |
US8362268B2 (en) * | 2008-05-30 | 2013-01-29 | University Of Notre Dame Du Lac | Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria |
GB0818241D0 (en) * | 2008-10-06 | 2008-11-12 | Cancer Res Technology | Compounds and their use |
WO2010083199A1 (en) * | 2009-01-19 | 2010-07-22 | Abbott Laboratories | Benzthiazole inhibitors of poly(adp-ribose)polymerase |
WO2010126743A1 (en) | 2009-04-27 | 2010-11-04 | High Point Pharmaceuticals, Llc | SUBSTITUTED ISOQUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS β-SECRETASE INHIBITORS |
EP2436683B1 (en) * | 2009-05-29 | 2014-05-14 | Sumitomo Chemical Company, Limited | Agent for treatment or prevention of diseases associated with activity of neurotrophic factors |
US8513433B2 (en) * | 2009-07-02 | 2013-08-20 | Angion Biomedica Corp. | Small molecule inhibitors of PARP activity |
ES2620177T3 (es) * | 2009-10-15 | 2017-06-27 | Guerbet | Agentes de formación de imágenes y su uso para el diagnóstico in vivo de enfermedades neurodegenerativas, particularmente la enfermedad de Alzheimer y enfermedades derivadas |
BR112012012444A2 (pt) | 2009-11-27 | 2015-09-22 | Basf Plant Science Co Gmbh | "endonuclease quimérica, polinucleotídeo isolado, cassete de expressão, vetor, organismo não humano, método para fornecer uma endonuclease quimérica, método para recombinação homóloga de polinucleotídeos, método para mutação alvejada de polinucleotídeosa e método para recombinação homóloga ou mutação alvejada" |
WO2011064750A1 (en) | 2009-11-27 | 2011-06-03 | Basf Plant Science Company Gmbh | Chimeric endonucleases and uses thereof |
CN102725412B (zh) | 2009-11-27 | 2017-09-22 | 巴斯夫植物科学有限公司 | 优化的内切核酸酶及其用途 |
EP2549874A4 (en) * | 2010-03-23 | 2013-10-02 | High Point Pharmaceuticals Llc | SUBSTITUTED IMIDAZOLE [1,2-B] PYRIDAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS BETA-SECRETASE INHIBITORS |
UA109688C2 (xx) | 2010-12-16 | 2015-09-25 | Трициклічні інгібітори pі3k та їх застосування | |
MX2013008822A (es) * | 2011-02-09 | 2013-10-07 | Hoffmann La Roche | Compuestos heterociclicos como inhibidores de cinasa fosfatidilinositol-3 (pi3). |
KR101827444B1 (ko) | 2012-02-01 | 2018-02-08 | 제일약품주식회사 | 트리사이클로 유도체 화합물의 신규한 결정형 산부가염 또는 이의 수화물 및 이의 제조방법 |
US9309247B2 (en) | 2013-03-20 | 2016-04-12 | Lorus Therapeutics Inc. | 2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer |
CN104140426B (zh) * | 2013-05-07 | 2017-02-01 | 上海汇伦生命科技有限公司 | 嘧啶并咪唑类化合物、其药物组合物及其制备方法和用途 |
CN105263913B (zh) * | 2013-06-14 | 2017-12-15 | 广东东阳光药业有限公司 | 硫代1,2,4‑***衍生物及其制备方法 |
CN104230896A (zh) * | 2013-06-17 | 2014-12-24 | 上海汇伦生命科技有限公司 | 苯并咪唑-2-哌嗪杂环类化合物、其药物组合物及其制备方法和用途 |
WO2015051302A1 (en) | 2013-10-04 | 2015-04-09 | Aptose Biosciences Inc. | Compositions and methods for treating cancers |
CN103936719A (zh) * | 2014-05-14 | 2014-07-23 | 中国药科大学 | 苯并咪唑类衍生物制备方法及用途 |
ES2949192T3 (es) | 2015-05-28 | 2023-09-26 | Ecolab Usa Inc | Inhibidores de la corrosión de bencimidazol sustituido en 2 |
CA2987248C (en) * | 2015-05-28 | 2023-09-26 | Ecolab Usa Inc. | Novel corrosion inhibitors |
EP3357925B1 (en) | 2015-09-30 | 2021-10-27 | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | Salt type and crystal type of 4h-pyrazolo [1, 5-alpha]benzimidazole compound and preparation method and intermediate thereof |
CN105712937B (zh) * | 2016-02-28 | 2019-02-22 | 河北宁格生物医药科技有限公司 | 一种治疗转移性肿瘤的化合物及其用途 |
JP2021501203A (ja) | 2017-10-30 | 2021-01-14 | アプトース バイオサイエンシズ インコーポレイテッド | がん治療用のアリールイミダゾール |
AU2019205325A1 (en) | 2018-01-05 | 2020-08-13 | Cybrexa 1, Inc. | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues |
AU2019387370A1 (en) | 2018-11-30 | 2021-06-10 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
EP3996749A1 (en) | 2019-07-10 | 2022-05-18 | Cybrexa 3, Inc. | Peptide conjugates of microtubule-targeting agents as therapeutics |
WO2021007435A1 (en) | 2019-07-10 | 2021-01-14 | Cybrexa 2, Inc. | Peptide conjugates of cytotoxins as therapeutics |
CR20230378A (es) | 2021-01-08 | 2023-10-27 | Cybrexa 2 Inc | Proceso para preparar un resto enlazador de conjugados |
WO2022155172A1 (en) | 2021-01-13 | 2022-07-21 | Cybrexa 3, Inc. | Peptide conjugates of therapeutics |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA885929B (en) * | 1987-08-25 | 1989-04-26 | Oxi Gene Inc | Agents for use in tumor or cancer cell killing therapy |
AP866A (en) * | 1995-08-02 | 2000-08-17 | Newcastle Univ Ventures Limited | Benzimidazole compounds. |
WO1997048697A1 (en) * | 1996-06-19 | 1997-12-24 | Rhone-Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
TR200101239T2 (tr) * | 1998-11-03 | 2001-11-21 | Basf Aktiengesellschaft | İkameli-2-fenilbenzimidazoller, üretimleri ve kullanımları |
IL143102A0 (en) * | 1998-11-17 | 2002-04-21 | Basf Ag | 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
PL196367B1 (pl) * | 1998-11-27 | 2007-12-31 | Basf Ag | Podstawione benzimidazole, ich zastosowanie jako inhibitorów PARP oraz środek leczniczy |
-
1999
- 1999-05-07 DE DE19920936A patent/DE19920936A1/de not_active Withdrawn
-
2000
- 2000-04-27 CN CN00808364A patent/CN1353695A/zh active Pending
- 2000-04-27 HU HU0202970A patent/HUP0202970A2/hu unknown
- 2000-04-27 JP JP2000617186A patent/JP4004737B2/ja not_active Expired - Fee Related
- 2000-04-27 AT AT00927088T patent/ATE286029T1/de active
- 2000-04-27 DK DK00927088T patent/DK1177178T3/da active
- 2000-04-27 SK SK1596-2001A patent/SK15962001A3/sk unknown
- 2000-04-27 UA UA2001128419A patent/UA68436C2/uk unknown
- 2000-04-27 BR BR0010342-0A patent/BR0010342A/pt not_active IP Right Cessation
- 2000-04-27 KR KR1020017014145A patent/KR20010112477A/ko not_active Application Discontinuation
- 2000-04-27 AU AU45584/00A patent/AU4558400A/en not_active Abandoned
- 2000-04-27 DE DE50009118T patent/DE50009118D1/de not_active Expired - Lifetime
- 2000-04-27 PL PL00351558A patent/PL351558A1/xx not_active Application Discontinuation
- 2000-04-27 CA CA002371645A patent/CA2371645C/en not_active Expired - Fee Related
- 2000-04-27 ES ES00927088T patent/ES2235869T3/es not_active Expired - Lifetime
- 2000-04-27 US US09/959,632 patent/US6696437B1/en not_active Expired - Lifetime
- 2000-04-27 EP EP00927088A patent/EP1177178B1/de not_active Expired - Lifetime
- 2000-04-27 IL IL14614700A patent/IL146147A0/xx unknown
- 2000-04-27 PT PT00927088T patent/PT1177178E/pt unknown
- 2000-04-27 TR TR2001/03221T patent/TR200103221T2/tr unknown
- 2000-04-27 WO PCT/EP2000/003813 patent/WO2000068206A1/de not_active Application Discontinuation
- 2000-05-05 MY MYPI20001934A patent/MY122771A/en unknown
- 2000-05-05 AR ARP000102178A patent/AR029161A1/es unknown
- 2000-05-05 CO CO00032472A patent/CO5170517A1/es not_active Application Discontinuation
-
2001
- 2001-10-19 ZA ZA200108609A patent/ZA200108609B/en unknown
- 2001-10-22 BG BG106035A patent/BG106035A/xx unknown
- 2001-11-02 NO NO20015362A patent/NO20015362L/no not_active Application Discontinuation
-
2002
- 2002-10-30 HK HK02107871.7A patent/HK1046281A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
PL351558A1 (en) | 2003-05-05 |
CA2371645A1 (en) | 2000-11-16 |
DE19920936A1 (de) | 2000-11-09 |
ES2235869T3 (es) | 2005-07-16 |
AU4558400A (en) | 2000-11-21 |
BR0010342A (pt) | 2002-05-28 |
NO20015362D0 (no) | 2001-11-02 |
CN1353695A (zh) | 2002-06-12 |
NO20015362L (no) | 2001-11-02 |
EP1177178B1 (de) | 2004-12-29 |
CA2371645C (en) | 2007-04-17 |
EP1177178A1 (de) | 2002-02-06 |
PT1177178E (pt) | 2005-05-31 |
CO5170517A1 (es) | 2002-06-27 |
BG106035A (en) | 2002-06-28 |
AR029161A1 (es) | 2003-06-18 |
JP2002544199A (ja) | 2002-12-24 |
JP4004737B2 (ja) | 2007-11-07 |
ATE286029T1 (de) | 2005-01-15 |
HK1046281A1 (zh) | 2003-01-03 |
IL146147A0 (en) | 2002-07-25 |
ZA200108609B (en) | 2002-10-21 |
WO2000068206A1 (de) | 2000-11-16 |
KR20010112477A (ko) | 2001-12-20 |
MY122771A (en) | 2006-05-31 |
US6696437B1 (en) | 2004-02-24 |
DE50009118D1 (de) | 2005-02-03 |
DK1177178T3 (da) | 2005-05-02 |
HUP0202970A2 (hu) | 2002-12-28 |
SK15962001A3 (sk) | 2002-06-04 |
UA68436C2 (en) | 2004-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200103221T2 (tr) | Heterosiklik olarak ikame edilmiş benzimidazoller, bunların üretimi ve uygulanması | |
TR200101400T2 (tr) | 2-Fenilbenzimidazoller ve 2-fenilindoller, hazırlanmaları ve kullanımları | |
NO20015462D0 (no) | Anvendelse av fthalazinderivater | |
BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
DE60218458D1 (de) | Isochinolinon derivate als parp inhibitoren | |
BR9909994A (pt) | Quinolinas usadas como inibidores de mrs e bactericidas | |
ATE320457T1 (de) | Polyurethanlösungen mit alkoxysilanstruktureinheiten | |
NO20011174L (no) | Nye heteroaromatiske inhibitorer av fruktose-1,6-bisfosfotase | |
BR0011130A (pt) | Inibidores de metaloproteases | |
ATE342097T1 (de) | Elektroaktive pore | |
BR0008176A (pt) | Derivados anti-convulsivantes úteis no tratamento de cefaléias em cacho | |
EE200000033A (et) | Uudsed tetrasoolderivaadid | |
WO2001027118A3 (de) | Bicyclische imidazo-5-yl-aminderivate | |
DK1109810T3 (da) | Benzonaphthydin-N-oxider med PDE3- og PDE4-inhiberende aktivitet | |
SI1147103T1 (en) | Phenantrhridine-n-oxides with pde-iv inhibiting activity | |
NO20020031L (no) | Dihydrobenzodiazepiner og deres anvendelse til behandling av dyslipidemi | |
PT1147088E (pt) | 6-arilfenantridinas com actividade inibitoria da pde-iv | |
PT1147087E (pt) | Feantridina-n-oxidos com actividade de inibicao de pde-iv | |
TR200402030T4 (tr) | İkame edilen I-aminobutan-3-ol-türevleri | |
BR9814188A (pt) | "agonistas de 5-ht1f" | |
PT1244643E (pt) | Inibidores da triptase | |
PT1244614E (pt) | Inibidores de triptase | |
ATE241640T1 (de) | Fusidinsäure-derivate | |
DE50008686D1 (de) | Lytisches enzym | |
ATE348803T1 (de) | Tryptase-inhibitoren |